Home/ Stocks/ DVA

DaVita Inc.

DVA XNYS

$198.65 +2.39 (+1.22%) ▲ 15-min delayed

Open

$196.59

High

$199.27

Low

$193.85

Volume

1.13M

Market Cap

$12.75B

About DaVita Inc.

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Sector: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC Employees: 78.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$3.42B	$275.04M	$2.93
FY 2025	$13.64B	$1.08B	$10.06
Q3 2025	$3.42B	$240.25M	$2.09
Q2 2025	$3.38B	$275.22M	$2.62

Related Market News

No specific coverage for DVA yet. Check out our latest market news or earnings calendar.

Get DVA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on DaVita Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.